These findings provide further support that both DMP-1 and integrin αvβ3 are critical mediators in the pathogenesis of aortic valve calcification and may represent combinational therapeutic targets for CAVD. Here, DMP1 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.